BLM hydrolase Antibodies

Santa Cruz Biotechnology features a diverse variety of BLM hydrolase monoclonal antibodies for research applications. BLM hydrolase monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BLM hydrolase plays a critical role in DNA repair and maintenance, specifically in the resolution of DNA structures that can lead to genomic instability. BLM hydrolase activity is essential for the proper functioning of cellular processes, and alterations in BLM hydrolase function have been implicated in various diseases, including cancer. Understanding BLM hydrolase mechanisms is crucial for advancing therapeutic strategies and improving disease outcomes. Researchers can utilize BLM hydrolase monoclonal antibodies to investigate DNA repair pathways and cellular responses to genomic stress. BLM hydrolase research continues to reveal new insights into genome stability and maintenance. Santa Cruz Biotechnology monoclonal antibodies for BLM hydrolase support researchers worldwide in advancing scientific understanding of DNA repair mechanisms and their impact on human health.